CRISPR-Cas systems and methods for altering expression of gene products
US8945839B2 · kind B2 · utility
416Cited by
0References
28Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Apr 18, 2014 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | Apr 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for systems, methods, and compositions for altering expression of target gene sequences and related gene products. Provided are vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for the design and use of such vectors. Also provided are methods of directing CRISPR complex formation in eukaryotic cells and methods for utilizing the CRISPR-Cas system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.